Zacks Investment Research lowered shares of Sartorius (OTCMKTS:SARTF) from a hold rating to a sell rating in a research report released on Tuesday.
According to Zacks, “Sartorius AG is a pharmaceutical and laboratory equipment supplier. The company manufactures equipment for biomolecular and microbial separations, cell culture, concentration, fermentation and purification. Sartorius AG is headquartered in Goettingen, Germany. “
Sartorius stock opened at $109.50 on Tuesday. Sartorius has a twelve month low of $109.50 and a twelve month high of $149.00. The company has a debt-to-equity ratio of 1.08, a current ratio of 1.62 and a quick ratio of 1.00.
Sartorius Company Profile
There is no company description available for Sartorius AG.
Recommended Story: Preferred Stock
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with MarketBeat.com's FREE daily email newsletter.